Several authors have already shown that TG2 activity is increased in patients afflicted with Alzheimer’s disease (AD) and HD as compared to healthy subjects, which suggests that TG2 activity may contribute to the detrimental effects observed in affected individuals [33,34,35]. This evidence concerns the gene TGM2 and Alzheimer disease.